Roche Holding AG (RHHBY)
35.44
+0.15
(+0.43%)
USD |
OTCM |
Nov 22, 16:24
Roche Shareholders Equity (Quarterly): 32.20B for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 32.20B |
June 30, 2024 | 32.20B |
December 31, 2023 | 34.90B |
June 30, 2023 | 29.49B |
June 30, 2023 | 29.49B |
December 31, 2022 | 30.19B |
June 30, 2022 | 26.39B |
June 30, 2022 | 26.39B |
December 31, 2021 | 26.79B |
June 30, 2021 | 41.06B |
June 30, 2021 | 41.06B |
December 31, 2020 | 41.60B |
June 30, 2020 | 33.13B |
June 30, 2020 | 33.13B |
December 31, 2019 | 33.80B |
June 30, 2019 | 28.72B |
June 30, 2019 | 28.72B |
December 31, 2018 | 28.06B |
June 30, 2018 | 27.41B |
June 30, 2018 | 27.41B |
December 31, 2017 | 27.14B |
June 30, 2017 | 23.88B |
June 30, 2017 | 23.88B |
December 31, 2016 | 23.50B |
June 30, 2016 | 18.84B |
Date | Value |
---|---|
June 30, 2016 | 18.84B |
December 31, 2015 | 21.22B |
June 30, 2015 | 18.47B |
June 30, 2015 | 18.47B |
December 31, 2014 | 19.81B |
June 30, 2014 | 19.54B |
June 30, 2014 | 19.54B |
December 31, 2013 | 21.74B |
June 30, 2013 | 14.76B |
June 30, 2013 | 14.76B |
December 31, 2012 | 15.90B |
June 30, 2012 | 9.961B |
June 30, 2012 | 9.961B |
December 31, 2011 | 12.88B |
June 30, 2011 | 10.60B |
June 30, 2011 | 10.60B |
December 31, 2010 | 10.13B |
June 30, 2010 | 5.139B |
December 31, 2009 | 7.113B |
June 30, 2009 | 3.105B |
December 31, 2008 | 41.62B |
June 30, 2008 | 40.74B |
June 30, 2008 | 40.74B |
December 31, 2007 | 40.13B |
June 30, 2007 | 34.74B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
26.39B
Minimum
Jun 2022
41.60B
Maximum
Dec 2020
32.79B
Average
32.20B
Median
Jun 2024
Shareholders Equity (Quarterly) Benchmarks
Novo Nordisk AS | 18.05B |
Pfizer Inc | 92.29B |
Amgen Inc | 7.527B |
Eli Lilly and Co | 14.24B |
Merck & Co Inc | 44.50B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 106.56B |
Total Liabilities (Quarterly) | 69.98B |
Debt to Equity Ratio | 1.19 |
Current Ratio | 1.264 |
Net Debt Paydown Yield | -1.65% |